Fiera Capital (Canada)
PBE icon

Fiera Capital (Canada)’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Fiera Capital (Canada)’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-16,870
Closed -$708K – 796
2016
Q3 		$708K Hold
16,870
– – ﹤0.01% 565
2016
Q2 		$624K Hold
16,870
– – ﹤0.01% 625
2016
Q1 		$646K Hold
16,870
– – ﹤0.01% 452
2015
Q4 		$852K Hold
16,870
– – 0.01% 443
2015
Q3 		$771K Buy
+16,870
New +$943K 0.01% 396

Other funds holding PBE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SAM
SignalPoint Asset Management Springfield, Missouri $411M AUM 23.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
TCM
Traynor Capital Management Malvern, Pennsylvania $1.7B AUM 39.15% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Fiera Capital (Canada)'s PBE Position: Q4 2016 in Review

Fiera Capital (Canada) sold out of Invesco Biotechnology & Genome ETF (PBE) in Q4 2016, closing a stake of 16,870 shares — an estimated $708K sold.

Fiera Capital (Canada) first reported a position in PBE in Q3 2015 and held it in 5 quarters. The position peaked at $852K in Q4 2015. 68 funds tracked by Wall St. Rank hold PBE as of Q4 2016.

  • Fiera Capital (Canada) reported no remaining Invesco Biotechnology & Genome ETF position as of Q4 2016 after selling out during the quarter.
  • Fiera Capital (Canada) sold 16,870 Invesco Biotechnology & Genome ETF shares in Q4 2016, an estimated $708K.
  • Fiera Capital (Canada) first reported a position in Invesco Biotechnology & Genome ETF in Q3 2015 and held it in 5 quarters.
  • Fiera Capital (Canada)'s Invesco Biotechnology & Genome ETF position peaked at $852K in Q4 2015.
  • 68 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q4 2016.

Based on Fiera Capital (Canada)'s 13F filing for Q4 2016, filed 14 Feb 2017.